Antiglycation properties of aged garlic extract: Possible role in prevention of diabetic complications

Journal of Nutrition

Volumn 136, Issue 3, 2006, Pages

  Ahmad, Muhammed Saeed ^a   Ahmed, Nessar ^a  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Aged garlic extract; Diabetes mellitus; Glycation; Hyperglycemia; S allylcysteine

Indexed keywords

ADVANCED GLYCATION END PRODUCT; FREE RADICAL; GARLIC EXTRACT; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOW DENSITY LIPOPROTEIN; S ALLYLCYSTEINE;

ANTIOXIDANT ACTIVITY; AUTOOXIDATION; CONFERENCE PAPER; DIABETES MELLITUS; DRUG INHIBITION; GLUCOSE BLOOD LEVEL; GLYCATION; HUMAN; IN VITRO STUDY; OXIDATIVE STRESS; THROMBOCYTE AGGREGATION;

ALLIUM SATIVUM;

EID: 33644847340     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/136.3.796s     Document Type: Conference Paper

References (29)

1. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993;328:1676-85.
2. DCCT Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin dependent diabetes mellitus; the diabetes control and complications trial. N Engl J Med. 1993;329:977-86.
3. UKPDS. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type II diabetes: (UKPDS 33). Lancet. 1998;352:837-51.
4. Sell DR, Monnier VM. Structure elucidation of a senescence cross-link from human extracellular matrix. J Biol Chem. 1989;264:21597-602.
5. Al-Abed Y, Bucala R. Structure of a synthetic glucose derived advanced glycation end product that is immunologically cross-reactive with its naturally occurring counterparts. Bioconjug Chem. 2000;11:39-45.
6. Portero-Otin M, Nagaraj RH, Monnier VM. Chromatographic evidence for pyrraline formation during protein glycation in vitro and in vivo. Biochim Biophys Acta. 1995;1247:74-86.
7. Hunt JV, Bottoms MA, Mitchinson MJ. Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Biochem J. 1993;291:529-35.
8. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care. 2002;5:561-8.
9. Vlassara H, Palace MR. Diabetes and advanced glycation endproducts. J Intern Med. 2002;251:87-101.
10. Ahmed N. Advanced glycation endproducts - role in pathology of diabetic complications. Diabetes Res Clin Pract. 2005;67:3-21.
11. Yan S, Schmidt A-M, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation endproducts with their receptors/binding proteins. J Biol Chem. 1994;269:9889-97.
12. Monnier VM. Intervention against the Maillard reaction in vivo. Arch Biochem Biophys. 2003;419:1-15.
13. Vasan S, Foiles P, Founds H. Therapeutic potential of breakers of advanced glycation endproduct-protein crosslinks. Arch Biochem Biophys. 2003;419:89-96.
14. Stern DM, Yan SD, Yan SF, Schmidt A-M. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes. Ageing Res Rev. 2002;1:1-15.
15. Thornalley PJ. Use of aminoguanidine (pimagedine) to prevent the formation of advanced glycation endproducts. Arch Biochem Biophys. 2003;419:31-40.
16. Rahbar S, Figarola JL. Novel inhibitors of advanced glycation endproducts. Arch Biochem Biophys. 2003;419:63-79.
17. Swamy MS, Abraham EC. Inhibition of lens crystalline glycation and high molecular weight aggregate formation by aspirin in vitro and in vivo. Invest Ophthalmol Vis Sci. 1989;30:1120-6.
18. Duraisamy Y, Gaffney J, Slevin M, Smith CA, Williamson K, Ahmed N. Aminosalicylic acid reduces the antiproliferative effect of hyperglycaemia, advanced glycation endproducts and glycated basic fibroblast growth factor in cultured bovine aortic endothelial cells: Comparison with aminoguanidine. Mol Cell Biochem. 2003;246:143-53.
19. Nakagawa T, Yokozawa T, Terasawa K, Shu S, Juneja LR. Protective activity of green tea against free radical- and glucose-mediated protein damage. J Agric Food Chem. 2002;50:2418-22.
20. Yamaguchi F, Ariga T, Yoshimura Y, Nakazawa H. Antioxidative and antiglycation activity of garcinol from Garcinia indica fruit rind. J Agric Food Chem. 2000;48:180-5.
21. Kiho T, Usui S, Hirano K, Aizawa K. Tomato paste fraction inhibiting the formation of advanced glycation endproducts. Biosci Biotechnol Biochem. 2004;68:200-5.
22. Rahman K. Garlic and aging: new insights into an old remedy. Ageing Res Rev. 2003;2:39-56.
23. Imai J, Ide N, Nagae S, Moriguchi T, Matsuura H, Itakura Y. Antioxidant and radical scavenging effects of aged garlic extract and its constituents. Planta Med. 1994;60:417-20.
24. Banerjee SK, Maulik SK. Effect of garlic on cardiovascular disorders: a review. Nutr J. 2002;1:4-17.
25. Dillon S. Antioxidant properties of aged garlic extract: an in vitro study incorporating human low density lipoprotein. Life Sci. 2003;72:1583-94.
26. Wei Z, Lau BHS. Garlic inhibits free radical generation and augments antioxidant enzyme activity in vascular endothelial cells. Nutr Res. 1998;18:61-70.
27. Cai W, Cao Q, Zhu L, Peppa M, He C, Vlassara H. Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction. Mol Med. 2002;8:337-46.
28. Lau BHS, Lam F, Wang-Cheng R. Effect of an odor-modified garlic preparation on blood lipids. Nutr Res. 1987;7:139-49.
29. Ou CC, Tsao SM, Lin MC, Yin MC. Protective action on human LDL against oxidation and glycation by four organosulfur compounds derived from garlic. Lipids. 2003;38:219-24.